These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27791253)

  • 21. Lubricant with gelling agent in treating dry eye in adult Chinese patients.
    Waduthantri S; Yong SS; Tan CH; Htoon HM; Tong L
    Optom Vis Sci; 2012 Nov; 89(11):1647-53. PubMed ID: 23069726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of using a combination of lid wipes, eye drops, and omega-3 supplements on meibomian gland functionality in patients with lipid deficient/evaporative dry eye.
    Korb DR; Blackie CA; Finnemore VM; Douglass T
    Cornea; 2015 Apr; 34(4):407-12. PubMed ID: 25651491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population.
    Hartstein I; Khwarg S; Przydryga J
    Curr Med Res Opin; 2005 Feb; 21(2):255-60. PubMed ID: 15801996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study.
    Kiss HJ; Németh J
    PLoS One; 2015; 10(7):e0132656. PubMed ID: 26172053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium.
    Rangarajan R; Kraybill B; Ogundele A; Ketelson HA
    J Ocul Pharmacol Ther; 2015 Oct; 31(8):491-7. PubMed ID: 26067908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of lipid-based dry eye supplements on the tear film in wearers of eye cosmetics.
    Wang MTM; Cho ISH; Jung SH; Craig JP
    Cont Lens Anterior Eye; 2017 Aug; 40(4):236-241. PubMed ID: 28292574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of polyethylene glycol-propylene glycol-based lubricant eye drops in reducing squamous metaplasia in patients with dry eye disease.
    Aguilar A; Berra M; Trédicce J; Berra A
    Clin Ophthalmol; 2018; 12():1237-1243. PubMed ID: 30034217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease.
    Srinivasan S; Williams R
    Clin Ophthalmol; 2022; 16():3311-3326. PubMed ID: 36237486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised controlled trial of topical antibacterial Manuka (Leptospermum species) honey for evaporative dry eye due to meibomian gland dysfunction.
    Albietz JM; Schmid KL
    Clin Exp Optom; 2017 Nov; 100(6):603-615. PubMed ID: 28585260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
    Utsunomiya T; Kawahara A; Hanada K; Yoshida A
    Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops.
    Gensheimer WG; Kleinman DM; Gonzalez MO; Sobti D; Cooper ER; Smits G; Loxley A; Mitchnick M; Aquavella JV
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):473-8. PubMed ID: 22554205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial.
    Silverstein S; Yeu E; Tauber J; Guillon M; Jones L; Galarreta D; Srinivasan S; Manoj V
    Clin Ophthalmol; 2020; 14():3167-3177. PubMed ID: 33116367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study.
    Vandermeer G; Chamy Y; Pisella PJ
    J Fr Ophtalmol; 2018 Feb; 41(2):e51-e57. PubMed ID: 29366588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease.
    Tauber J; Wirta DL; Sall K; Majmudar PA; Willen D; Krösser S;
    Cornea; 2021 Sep; 40(9):1132-1140. PubMed ID: 33369937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relieving the symptoms of dry eye disease: update on lubricating eye drops containing hydroxypropyl-guar.
    Garofalo R; Kunnen C; Rangarajan R; Manoj V; Ketelson H
    Clin Exp Optom; 2021 Nov; 104(8):826-834. PubMed ID: 34137675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel ocular lubricant containing an intelligent delivery system: details of its mechanism of action.
    Springs C
    Dev Ophthalmol; 2010; 45():139-147. PubMed ID: 20502034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution.
    Fernandez KB; Epstein SP; Raynor GS; Sheyman AT; Massingale ML; Dentone PG; Landegger LD; Asbell PA
    Clin Ophthalmol; 2015; 9():1137-45. PubMed ID: 26170605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eye.
    Jacobi C; Kruse FE; Cursiefen C
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):598-603. PubMed ID: 22813209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
    Tauber J; Karpecki P; Latkany R; Luchs J; Martel J; Sall K; Raychaudhuri A; Smith V; Semba CP;
    Ophthalmology; 2015 Dec; 122(12):2423-31. PubMed ID: 26365210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.